IBTK and mantle cell lymphoma: Likewise, Mino cells overexpressing a CARD11D357E mutant, which has been identified in MCL patients [15], also combine constitutive activation of the CBM complex with resistance to BTKi, while partially retaining the anti-proliferative capacity of KIN-8194 (Fig. 5F, G).